Evaluation of Pharmacists' Practice in Patient Education When Dispensing a Metered-Dose Inhaler

Abstract

Spanish

French

Improper inhalation technique with beta-agonist metered-dose inhalers (MDIs) decreases efficacy of the bronchodilator. The success of demonstrating the correct technique and the pharmacist's role in patient education has been reported. To obtain information regarding the routine patient education practice of pharmacists when dispensing a beta-agonist MDI (albuterol), the following study was performed. Fifty-two prescriptions for an albuterol MDI were presented to 52 randomly chosen community pharmacists in three Tennessee cities. Twenty-six independent and 26 chain pharmacies were evaluated. Pharmacists' practice with regard to patient education, instruction, and demonstration of the correct usage of the MDI was observed and recorded. Overall, 13 percent of the pharmacists initially offered to educate the patient-investigator (PI) regarding the correct usage of the MDI without being asked for information. Fifty-three percent of pharmacists offered information only upon being asked specifically how to use the MDI. Of the pharmacists who offered to educate the PI, 71 percent discussed less than half of the eight steps correctly. Only 1 of the 52 pharmacists actually demonstrated MDI inhalation technique, and this in response to a request. No pharmacist asked the PI to perform the technique while he/she observed. No pharmacist offered information on delivery enhancement devices. Our results demonstrate that few pharmacists educate patients on the correct usage of an MDI, and that many pharmacists are not aware of the correct technique.

Get full access to this article

View all access options for this article.

References

Shim

Williams

. Comparison of oral aminophylline and aerosol metaproterenol in asthma. Am J Med 1981; 71: 452–5.

Shim

Williams

. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease. Am J Med 1983; 75: 697–701.

Newhouse

Dolovich

. Control of asthma by aerosols. N Engl J Med 1986; 315: 870–4.

Orehek

Gayrard

Grimaud

Charpin

. Patient error in use of bronchodilator metered aerosols. Br Med J 1976; 1: 76.

Patterson

Crompton

. Use of pressurized aerosols by asthmatic patients. Br Med J 1976; 1: 76–7.

Epstein

Manning

Ashley

Corey

. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979; 120: 813–6.

Shim

Williams

. The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 1980; 69: 891–4.

Gayrard

Orehek

. Inadequate use of pressurized aerosols by asthmatic patients (abstract). Respiration 1980; 40: 47–52.

Lindgren

Bake

Larsson

. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis 1987; 70: 93–9.

10.

Rivlin

Mindorff

Levison

Kazim

Reilly

Worsley

. Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler. J Pediatr 1983; 102: 470–4.

11.

De Blaquiere

Christensen

Carter

Martin

. Use and misuse of metered-dose inhalers by patients with chronic lung disease: A controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989; 140: 910–6.

12.

Self

Brooks

Lieberman

Ryan

. The value of demonstration and role of the pharmacist in teaching the correct use of pressurized bronchodilators. Can Med Assoc J 1983; 128: 129–31.

13.

Roberts

Robinson

Doering

Dallman

Steeves

. A comparison of various types of patient instruction in the proper administration of metered inhalers. Drug Intell Clin Pharm 1982; 16: 53–9.

14.

Kelling

Strohl

Smith

Altose

. Physician knowledge in the use of canister nebulizers. Chest 1983; 83: 612–4.

15.

Burton

. Asthma inhalation devices: What do we know? Br Med J 1984; 288: 1650–1.

16.

Konig

. Spacer devices used with metered-dose inhalers: Breakthrough or gimmick? Chest 1985; 88: 276–84.

17.

Newman

Pavia

Clarke

. How should a pressurized β-adrenergic bronchodilator be inhaled? Eur J Respir Dis 1981; 62: 3–21.

18.

Knapp

Edwards

. The pharmacist as a drug advisor. J Am Pharm Assoc 1969; NS9: 502–5, 543.

19.

Campbell

Grisafe

. Compliance with the Washington state patient information regulation. J Am Pharm Assoc 1975; NS15: 494–5, 528.

20.

Ross

White

Hogan

Godwin

. The effect of mandatory counseling regulation on the counseling practices of pharmacy practitioners. Contemp Pharm Pract 1981; 4: 64–8.

21.

Mason

Svarstad

. Medication counseling behaviors and attitudes of rural community pharmacists. Drug Intell Clin Pharm 1984; 18: 409–14.

22.

Kirking

. Pharmacists' perceptions of their patient counseling activities. Contemp Pharm Pract 1982; 5: 230–8.

23.

Laurier

Archambault

Contandriopoulos

. Communication of verbal information by community pharmacists. Drug Intell Clin Pharm 1989; 23: 862–8.

24.

Henry

Sutherland

Francis

, And The Newcastle Retail Pharmacy Research Group. The use of non-prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South Wales. Med J Aust 1989; 150: 445–9.